EUR 148.98 For Business Accounts Only

Novo Nordisk A/S - Company Profile and SWOT Analysis

Summary

Novo Nordisk A/S - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novo Nordisk A/S (Novo Nordisk or 'the company') is a pharmaceutical company. It produces and develops biological medications with a primary focus on developing therapies for diabetes and other severe chronic ailments like hemophilia, abnormalities of human growth hormone (HGH), and obesity. Novo Nordisk's products include pre-filled delivery systems, and insulin; glucagon hypokit; needles; cartridge, oral antidiabetic agents and estradiol for hormone replacement. Its major products across different therapy areas include Tresiba, NovoRapid, Ryzodeg, Fiasp, Levemir, Insulatard, Rybelsus NovoPen,, NordiPen, Activelle, Vagifem, and others. Novo Nordisk has operations across North America, Asia, Europe, the Middle East and Africa. The company is headquartered in Bagsvaerd, Denmark.

Scope

Novo Nordisk A/S - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novo Nordisk A/S (Novo Nordisk or 'the company') is a pharmaceutical company. It produces and develops biological medications with a primary focus on developing therapies for diabetes and other severe chronic ailments like hemophilia, abnormalities of human growth hormone (HGH), and obesity. Novo Nordisk's products include pre-filled delivery systems, and insulin; glucagon hypokit; needles; cartridge, oral antidiabetic agents and estradiol for hormone replacement. Its major products across different therapy areas include Tresiba, NovoRapid, Ryzodeg, Fiasp, Levemir, Insulatard, Rybelsus NovoPen,, NordiPen, Activelle, Vagifem, and others. Novo Nordisk has operations across North America, Asia, Europe, the Middle East and Africa. The company is headquartered in Bagsvaerd, Denmark.

Reasons To Buy

- Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis
- An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments
- Intelligence on Novo Nordisk A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends